Rudolf Uher
Nova Scotia Health Authority · Nova Scotia Health Authority, Dalhousie University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rudolf Uher as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:36 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05017311 · Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)Nova Scotia Health Authority · recruiting · Major Depressive Disorder · principal investigator
- Ph2NCT05002309 · Treatment Interrupts Depression EarlyNova Scotia Health Authority · recruiting · Depression · principal investigator
- N/ANCT03601026 · Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis UseNova Scotia Health Authority · recruiting · Mental Illness, Schizophrenia, Bipolar Disorder · principal investigator
- N/ANCT03162211 · Feedback to Improve Depression OutcomesNova Scotia Health Authority · unknown · Depression · principal investigator
- Ph4NCT02752542 · Personalized Indications for CBT and Antidepressants in Treating DepressionNova Scotia Health Authority · recruiting · Major Depressive Disorder, Persistent Depressive Disorder · principal investigator
- N/ANCT02443636 · The Canadian Depression Research and Intervention Network (CDRIN) Maritimes RegistryNova Scotia Health Authority · recruiting · Depression, Post Traumatic Stress Disorder, Bipolar Disorder · principal investigator
- N/ANCT01980147 · Skills for WellnessNova Scotia Health Authority · recruiting · Schizophrenia, Bipolar Disorder, Major Depression · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:36 UTC. The ranking covers the 200 most relevant of 48 PubMed records, and a shared surname and initials can bring in a namesake. All 48 on PubMed
- Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.Neuropsychopharmacology · 2013347 citationsRCR 12.3
- Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.Psychol Med · 2012331 citationsRCR 11.9
- An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.Am J Psychiatry · 2014322 citationsRCR 12.1
- Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis.Proc Natl Acad Sci U S A · 2013267 citationsRCR 8.7
- Adverse reactions to antidepressants.Br J Psychiatry · 2009226 citationsRCR 8.1
- Cerebral processing of food-related stimuli: effects of fasting and gender.Behav Brain Res · 2006202 citationsRCR 5.8
- Self-report and clinician-rated measures of depression severity: can one replace the other?Depress Anxiety · 2012196 citationsRCR 8.1
- Functional neuroanatomy of body shape perception in healthy and eating-disordered women.Biol Psychiatry · 2005183 citationsRCR 5.8
- MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.Nat Commun · 2017173 citationsRCR 6.9
- Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.Br J Psychiatry · 2009155 citationsRCR 4.9